| | | | | | What you need to know about the coronavirus today | | | Poorer countries to get $5 tests Some 120 million rapid diagnostic tests for coronavirus will be made available to low- and middle-income countries at a maximum of $5 each, the World Health Organization (WHO) said on Monday.
The wider availability of quick, reliable and inexpensive testing will help 133 countries to track infections and contain the spread, closing the gap with wealthy ones, it said.
WHO Director General Tedros Adhanom Ghebreyesus said the manufacturers Abbott and SD Biosensor had agreed with the Bill & Melinda Gates Foundation to “make 120 million of these new, highly portable and easy-to-use rapid COVID-19 diagnostic tests available over a period of six months”.
Worrying trend in New York The percentage of COVID-19 tests taken in New York state that have come back positive has inched up to 1.5%, Governor Andrew Cuomo said on Monday, a worrisome trend for the former epicenter of the U.S. epidemic.
The rise comes as 27 other states recorded increases in the number of cases for two straight weeks.
While New York’s positive test rate remains much lower than those in some midwestern states where 15% of tests were coming back positive, it marks a significant uptick from the state’s rate, which has hovered at 1% or below for weeks.
“It’s not time to get tired because the virus isn’t tired,” Cuomo said.
Concerns over Trump adviser Two senior U.S. public health experts have raised concerns that White House adviser Scott Atlas is providing misleading or incorrect information on the coronavirus pandemic to President Donald Trump, according to media reports.
The top U.S. infectious diseases expert, Anthony Fauci, told CNN he was concerned that information given by Atlas - a late addition to the White House coronavirus task force - was “really taken either out of context or actually incorrect”.
The comments from Fauci, the head of the National Institute of Allergy and Infectious Diseases, came hours after a news report quoted Robert Redfield, director of the U.S. Centers for Disease Control and Prevention, sharing similar concerns.
Atlas, a neuroradiologist with no background in infectious diseases, has faced scrutiny for downplaying the importance of face masks and his reported views on “herd immunity”.
Russian scientist behind vaccine defends roll-out Russia plans to share preliminary results of its COVID-19 vaccine trial based on the first six weeks of monitoring participants, raising the tempo in an already frenzied global race to end the pandemic.
Alexander Gintsburg, head of the Gamaleya Institute that produced the Sputnik V vaccine, told Reuters the pace of its development was necessary under the “wartime” conditions of a pandemic but that no corners were being cut.
Russia has pushed ahead with its potential COVID-19 vaccine at top speed with mass public vaccinations alongside the main human trial.
“People are dying just like during a war,” said Gintsburg. “But this fast-tracked pace is not synonymous, as some media have suggested, with corners being cut. No way.” | | | | | | Reuters reporters and editors around the world are investigating the response to the coronavirus pandemic.
We need your help to tell these stories. Our news organization wants to capture the full scope of what’s happening and how we got here by drawing on a wide variety of sources.
Are you a government employee or contractor involved in coronavirus testing or the wider public health response? Are you a doctor, nurse or health worker caring for patients? Have you worked on similar outbreaks in the past? Has the disease known as COVID-19 personally affected you or your family? Are you aware of new problems that are about to emerge, such as critical supply shortages?
We need your tips, firsthand accounts, relevant documents or expert knowledge. Please contact us at coronavirus@reuters.com.
We prefer tips from named sources, but if you’d rather remain anonymous, you can submit a confidential news tip. Here’s how. | | | | | | | | | | Top Stories on Reuters TV | | | | | | | |
没有评论:
发表评论